Interleukin‐6 positively correlates with cardiovascular disease predictor algorithms and biomarker in rheumatoid arthritis patients
Journal of Cellular and Molecular Medicine · 2024-08 · 28 (16)
DOI: 10.1111/jcmm.70028 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, online erschienen am 19.08.2024. Verfasst von Seyed Askar Roghani und 7 weiteren Autor:innen. Beteiligte Einrichtung: Immunology Department, Faculty of Medicine, Kermanshah University of Medical Sciences, Kermanshah, Iran. Hauptthemen laut MEDLINE: Arthritis, Rheumatoid, Biomarkers, Interleukin-6, Cardiovascular Diseases. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deputy for Research and Technology, Kermanshah University of Medical Sciences.
Abstract (Originalsprache)
Chronic inflammation is believed as the main culprit of the link between cardiovascular disease (CVD) and rheumatoid arthritis (RA). Interleukin‐6 (IL‐6) is a pro‐inflammatory cytokine with a key role in RA pathophysiology and also correlates with joint destruction and disease activity. This study evaluates the association between IL‐6 plasma level and cardiac biomarker NT‐proBNP, HS‐CRP, CVD predictor algorithms, Framingham Risk Score (FRS) and Systematic Coronary Risk Evaluation (SCORE), as well as with CXCL9 and its receptor, CXCR3 in RA patients compared to the controls. Sixty RA patients (30 early and 30 late) and 30 healthy persons were included in this study. IL‐6 and NT‐proBNP plasma levels were measured by the ELISA. Also, HS‐CRP plasma levels were quantified using the immunoturbidimetric assay. The CVD risk was assessed by the FRS and SCORE. IL‐6 plasma levels were significantly higher in the early and late RA patients compared to the controls ( p < 0.001). There was a positive correlation between IL‐6 with DAS‐28 ( p = 0.007, r = 0.346), BPS ( p = 0.002, r = 0.396), BPD ( p = 0.046, r = 0.259), SCORE ( p < 0.001, r = 0.472), and FRS ( p < 0.001, r = 0.553), and a negative association with HDL ( p = 0.037, r = −0.270), in the patients. Also, IL‐6 plasma level positively correlated with HS‐CRP ( p = 0.021, r = 0.297) and NT‐proBNP ( p = 0.045, r = 0.260) in the patients. Furthermore, a positive association was found between IL‐6 plasma levels and CXCL9 ( p = 0.002, r = 0.386), and CXCR3 ( p = 0.018, r = 0.304) in the patients. Given the interesting association between IL‐6 with various variables of CVD, IL‐6 may be considered a biomarker for assessing the risk for future cardiovascular events in RA patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Immunology Department, Faculty of Medicine, Kermanshah University of Medical Sciences, Kermanshah, Iran.
- Clinical Research Development Center, Imam Reza Hospital, Kermanshah University of Medical Sciences, Kermanshah, Iran.
- Medical Biology Research Center, Health Technology Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran.
- University of Adelaide, Adelaide, South Australia, Australia.
- Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine, Tehran, Iran.
- Clinical Research Development Center, Tohid Hospital, Kurdistan University of Medical Sciences, Sanandaj, Iran.
ORCID-Profile: Ramin Lotfi, Mahdi Taghadosi
Förderung
- Deputy for Research and Technology, Kermanshah University of Medical Sciences
Zitieren
APA
Roghani, S. A., Shamsi, A., Jalili, C., Jalili, F., Lotfi, R., Garman, N., Rostampour, R., & Taghadosi, M. (2024). Interleukin‐6 positively correlates with cardiovascular disease predictor algorithms and biomarker in rheumatoid arthritis patients. Journal of Cellular and Molecular Medicine, 28(16). https://doi.org/10.1111/jcmm.70028
Vancouver
Roghani SA, Shamsi A, Jalili C, Jalili F, Lotfi R, Garman N, et al. Interleukin‐6 positively correlates with cardiovascular disease predictor algorithms and biomarker in rheumatoid arthritis patients. Journal of Cellular and Molecular Medicine. 2024;28(16). doi:10.1111/jcmm.70028
BibTeX
@article{Roghani2024,
author = {Roghani, Seyed Askar and Shamsi, Afsaneh and Jalili, Cyrus and Jalili, Farnaz and Lotfi, Ramin and Garman, Nima and Rostampour, Rezvan and Taghadosi, Mahdi},
title = {Interleukin‐6 positively correlates with cardiovascular disease predictor algorithms and biomarker in rheumatoid arthritis patients},
journal = {Journal of Cellular and Molecular Medicine},
year = {2024},
volume = {28},
number = {16},
doi = {10.1111/jcmm.70028}
}
EUVIMED